Keywords: idec, shares, soar, rituxan, news, pharmaceuticals, rose

IDEC Shares Soar On Rituxan News

Article | 03 June 1999

Shares in IDEC Pharmaceuticals rose $7.56 to reach $58.00 onexpectations that sales of Rituxan (rituximab) will outstrip analysts' forecasts, reports Bloomberg. In ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Rituxan

Rituximab

Go to drug listing